Advance Search
SHI Hui, FAN Jian, WANG Wei, WANG Kaijian, NI Xiaodong, FAN Chunsun. Analysis of prognostic factors and competing risks in 14, 805 cases with tonsil squamous cell carcinoma from the SEER database[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 42-46, 51. DOI: 10.7619/jcmp.20244248
Citation: SHI Hui, FAN Jian, WANG Wei, WANG Kaijian, NI Xiaodong, FAN Chunsun. Analysis of prognostic factors and competing risks in 14, 805 cases with tonsil squamous cell carcinoma from the SEER database[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 42-46, 51. DOI: 10.7619/jcmp.20244248
shu

Analysis of prognostic factors and competing risks in 14, 805 cases with tonsil squamous cell carcinoma from the SEER database

  • 1.

    Clinical Research Center, Qidong Hospital Affiliated to Nantong University, Qidong City People's Hospital, Qidong Liver Cancer Prevention and Control Institute, Qidong, Jiangsu, 226200

  • 2.

    Department of Otolaryngology-Head and Neck Surgery, Qidong Hospital Affiliated to Nantong University, Qidong City People's Hospital, Qidong Liver Cancer Prevention and Control Institute, Qidong, Jiangsu, 226200

More Information
  • Received Date: September 13, 2024
  • Revised Date: October 27, 2024
    Graphical Abstract
    • Abstract
  • Objective 

    To evaluate factors associated with prognosis of tonsil squamous cell carcinoma (TSCC) patients and analyze the competing risks of death in TSCC patients.

    Methods 

    Data tonsil malignant tumors cases diagnosed between 1975 and 2020 were obtained from the SEER database, and records confirmed as squamous cell carcinoma were selected. A Cox proportional hazards regression model was used to investigate the relationships of gender, race, age, marital status, year of diagnosis, lesion location, pathological evidence, treatment regimen with overall survival rate as well as cause-specific mortality outcomes. The competing risks of cause-specific death outcomes among TSCC patients with different clinical characteristics were assessed.

    Results 

    This study included 14, 805 TSCC patients, including 11, 650 males, accounting for 78.69%. 93.99% of TSCC cases were diagnosed after the age of 45, with the highest incidence occurring in 45 to 64 age group. Radiotherapy was the most commonly used treatment modality (81.78%), compared to surgery (49.47%) and chemotherapy (47.10%). By the end of the follow-up period, 8, 003 (54.06%) TSCC patients had died, with a median survival time of 2.33 years. Cox proportional hazards regression analysis showed that the HR (95%CI) for TSCC-related deaths among patients not receiving surgery, radiotherapy and chemotherapy were 2.101 (1.972 to 2.239), 1.829 (1.702 to 1.966) and 1.023(0.951 to 1.100), respectively, compared to those who did receive these treatments; the HR (95%CI) for deaths due to other causes were 1.630 (1.513 to 1.756), 1.438 (1.318 to 1.570) and 1.328 (1.212 to 1.456), respectively. Compared to patients < 45 years old, the HR (95%CI) for TSCC-related deaths among patients ≥65 years old were 2.218 (1.933 to 2.545), and for deaths due to other causes were 6.178 (5.133 to 7.436).

    Conclusion 

    Radiotherapy, surgery and chemotherapy all contribute to improving the prognosis of TSCC patients. For elderly TSCC patients, particular attention should be paid to non-TSCC-related death risks.

    • FullText(HTML)
    • References (22)
  • [1]
    BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263. doi: 10.3322/caac.21834
    [2]
    SIEGEL R L, GIAQUINTO A N, JEMAL A. Cancer statistics, 2024[J]. CA Cancer J Clin, 2024, 74(1): 12-49. doi: 10.3322/caac.21820
    [3]
    郑荣寿, 陈茹, 韩冰峰, 等. 2022年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2024, 46(3): 221-231. doi: 10.3760/cma.j.cn112152-20240119-00035
    [4]
    CHOW L Q M. Head and neck cancer[J]. N Engl J Med, 2020, 382(1): 60-72. doi: 10.1056/NEJMra1715715
    [5]
    黄志刚, 文卫平, 毛薇, 等. 头颈肿瘤的综合治疗策略[J]. 临床耳鼻咽喉头颈外科杂志, 2023, 37(9): 673-690.
    [6]
    布洁, 高黎, 徐国镇, 等. 160例扁桃体癌的放射治疗及预后[J]. 中华放射肿瘤学杂志, 2001, 10(2): 104-107. doi: 10.3760/j.issn:1004-4221.2001
    [7]
    吴雪溪, 唐平章, 祁永发, 等. 108例扁桃体鳞癌治疗效果的回顾性分析[J]. 癌症, 2003, 22(10): 1070-1073.
    [8]
    王馨, 谢方云, 韩非, 等. 扁桃体癌治疗及预后因素分析[J]. 中华耳鼻咽喉头颈外科杂志, 2009, 44(10): 848-852. doi: 10.3760/cma.j.issn.1673-0860.2009.10.015
    [9]
    聂志强, 欧艳秋, 曲艳吉, 等. 临床生存数据新视角: 竞争风险模型[J]. 中华流行病学杂志, 2017, 38(8): 1127-1131. doi: 10.3760/cma.j.issn.0254-6450.2017.08.026
    [10]
    朱莹莹, 刁文雯, 祝小莉, 等. 晚期扁桃体鳞状细胞癌手术治疗与非手术治疗的疗效比较[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(1): 42-47. doi: 10.3760/cma.j.cn115330-20210202-00053
    [11]
    CHE W Q, LI Y J, TSANG C K, et al. How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology[J]. Mil Med Res, 2023, 10(1): 50.
    [12]
    解松刚, 梁成通, 周丽娟, 等. 乳腺癌肺转移患者预后危险因素的分析及诺模图的构建[J]. 实用临床医药杂志, 2022, 26(18): 48-56. doi: 10.7619/jcmp.20220717
    [13]
    廖志晓, 邓跃扬, 朱津丽, 等. 早发性结直肠癌患者死亡竞争风险模型的构建[J]. 实用临床医药杂志, 2022, 26(22): 72-76. doi: 10.7619/jcmp.20222444
    [14]
    LI C Z, YANG J, ZHENG S, et al. Establishment and validation of a nomogram for tonsil squamous cell carcinoma: a retrospective study based on the SEER database[J]. Cancer Control, 2020, 27(1): 1073274820960481. doi: 10.1177/1073274820960481
    [15]
    陈绪清, 廖红明, 颜风波, 等. 基于SEER数据库的老年下咽癌患者预后预测模型建立与验证[J]. 国际耳鼻咽喉头颈外科杂志, 2023, 47(1): 13-18.
    [16]
    PARMAR A, MACLUSKEY M, GOLDRICK N M, et al. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy[J]. Cochrane Database Syst Rev, 2021, 12(12): CD006386.
    [17]
    中华口腔医学会口腔病理学专业委员会. 口腔癌及口咽癌病理诊断规范[J]. 中国口腔颌面外科杂志, 2020, 18(4): 289-296.
    [18]
    LECHNER M, LIU J, MASTERSON L, et al. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management[J]. Nat Rev Clin Oncol, 2022, 19(5): 306-327. doi: 10.1038/s41571-022-00603-7
    [19]
    LI Y B, JIANG B F, HUANG M D, et al. Retrospective study of the clinicopathological characteristics and prognosis of elderly patients with oropharyngeal squamous cell carcinoma[J]. J Int Med Res, 2021, 49(6): 3000605211016662. doi: 10.1177/03000605211016662
    [20]
    CHERAGHLOU S, YU P K, OTREMBA M D, et al. Treatment deintensification in human papillomavirus-positive oropharynx cancer: outcomes from the National Cancer Data Base[J]. Cancer, 2018, 124(4): 717-726. doi: 10.1002/cncr.31104
    [21]
    李卫芹, 杨雷, 王胜锋, 等. 生存数据的多状态竞争风险模型分析方法探索[J]. 中华预防医学杂志, 2021, 55(12): 1524-1529. doi: 10.3760/cma.j.cn112150-20211103-01019
    [22]
    朱志高, 梁凯. 口咽鳞状细胞癌患者预后影响因素分析[J]. 实用临床医药杂志, 2013, 17(11): 44-46, 49. doi: 10.7619/jcmp.201311014
    • Related Articles

  • Related Articles

    [1]LI Lijuan, WU Jie, SHANG Xinxiu, FENG Weixun. Efficacy of Xingpi Huazhuo Prescription in treating pre-diabetic patients with phlegm-dampness constitution and its influences on blood glucose and renal function indexes[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 60-63. DOI: 10.7619/jcmp.20242530
    [2]MAO Caifeng, WEI Namin, WANG Taibin, QIAO Yushan, FAN Ruijie, LI Zefa. Correlations of serum eukaryotic translation promoter 2α and activated transcription factor 4 levels with renal tissue injury and renal function in diabetic nephropathy patients[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 73-77. DOI: 10.7619/jcmp.20233794
    [3]SU Jianpei, WANG Yongli, WANG Zhimin, WU Qi, GU Jun, LI Jin, LIANG Bijuan. Effects of dapagliflozin on inflammatory cytokines and cardiac function in elderly patients with preserved ejection fraction heart failure complicated with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 85-89,95. DOI: 10.7619/jcmp.20233206
    [4]GUO Caixia, HU Ying, XU Suhong, ZHANG Chunhong, MENG Junhua. Effect of dulaptide combined with dapagliflozin and telmisartan in the treatment of diabetes mellitus complicating with cardiorenal insufficiency[J]. Journal of Clinical Medicine in Practice, 2023, 27(20): 118-121, 126. DOI: 10.7619/jcmp.20232150
    [5]JIN Qianqian, LI Huajun, WANG Xiaoyun, WANG Yuansong, DONG Yanfang, KONG Wubao, SUN Yunchuan, ZHAO Hongmin, NIU Yuelong. Expression of significance of serum secreted frizzled-related protein-4, lipoxygenase A4 and chemerin in patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 41-45, 64. DOI: 10.7619/jcmp.20221844
    [6]LIAO Jinlan, WEI Qijie, HE Yingying, LIAO Yumei, XIONG Zibo, WANG Qing, DING Dayong, HUANG Xiaoyan, XIONG Zuying. Clinical application of fundus vascular parameters and cognitive function evaluation in patients with diabetes undergoing peritoneal dialysis[J]. Journal of Clinical Medicine in Practice, 2022, 26(1): 85-88. DOI: 10.7619/jcmp.20213252
    [7]MAI Huade, SONG Yanling, CHEN Minghui, GU Shenhong. Effects of metformin combined with glimepiride or dapagliflozin on islet function and quality of life in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 61-64, 69. DOI: 10.7619/jcmp.20211691
    [8]LI Chengxiao, LIN Li, WANG Yanfeng. Effects of high flux hemodialysis and low flux hemodialysis for patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 98-101, 106. DOI: 10.7619/jcmp.20210307
    [9]LI Xiaoli. Correlation between serum IL-17, VEGF and renal indexes in patients with primary IgA nephropathy[J]. Journal of Clinical Medicine in Practice, 2017, (17): 92-95. DOI: 10.7619/jcmp.201717027
    [10]YU Xin. Efficacy of alogliptin combined with pioglitazone in treatment of patients with type 2 diabetes and its influence on improvement of islet β cell function[J]. Journal of Clinical Medicine in Practice, 2017, (9): 64-68. DOI: 10.7619/jcmp.201709017

  • Cited by

    Periodical cited type(5)

    1. 张小妹，徐松梅，沈腾珠，李娜. 安全缝隙多重阻断干预用于预防ICU谵妄的效果. 吉林医学. 2023(03): 781-784 .
    2. 周倩，邹小华，王丰，谌旻欢，全静，陈洁娟，高鸿. 心脏瓣膜置换术患者术中体外循环后并行时间的影响因素. 贵州医科大学学报. 2022(01): 85-89+95 .
    3. 李瑛，李贤煌，胡燕，肖伽，李冬英. 心脏外科术后患者发生谵妄危险因素的Meta分析. 解放军护理杂志. 2022(06): 72-76 .
    4. 徐晓航，高惠，赵季伟，王永祥，施学强，孙浩. 创伤中心严重多发伤患者发生谵妄的危险因素分析. 实用临床医药杂志. 2022(19): 38-41 . 本站查看
    5. 程灵娜. 术前心功能参数在心脏外科术后谵妄发生风险预测中的作用. 四川生理科学杂志. 2020(04): 419-422 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML
    Article views (96) PDF downloads (12) Cited by(7)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return